Katherine P. Hoversten
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Genetics 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Chronic Lymphocytic Leukemia Research 2
-
- Acute Myeloid Leukemia Research 4
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Naseema Gangat (6 shared papers)Ayalew Tefferi (5 shared papers)Mrinal Patnaik (5 shared papers)Christy M. Finke (5 shared papers)Terra L. Lasho (5 shared papers)Rhett P. Ketterling (5 shared papers)Narjust Duma (2 shared papers)Curtis A. Hanson (4 shared papers)
- Journals
- American Journal of Hematology (2 papers)The Oncologist (1 paper)Annals of Oncology (1 paper)Mayo Clinic Proceedings (1 paper)Leukemia (1 paper)
- Partner nations
- United States
In The Last Decade
Katherine P. Hoversten
11 papers receiving 366 citations
Peers
Comparison fields: 5 of 52
- Hematology 166
- Genetics 113
- Rehabilitation 24
- Oncology 81
- Public Health, Environmental and Occupational Health 46
Countries citing papers authored by Katherine P. Hoversten
This map shows the geographic impact of Katherine P. Hoversten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine P. Hoversten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine P. Hoversten more than expected).
Fields of papers citing papers by Katherine P. Hoversten
This network shows the impact of papers produced by Katherine P. Hoversten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine P. Hoversten. The network helps show where Katherine P. Hoversten may publish in the future.
Co-authors
The 25 scholars most cited alongside Katherine P. Hoversten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 112 | |
| 2 | 2017 | 63 | |
| 3 | 2018 | 43 | |
| 4 | 2017 | 38 | |
| 5 | 2020 | 38 | |
| 6 | 2018 | 26 | |
| 7 | 2018 | 26 | |
| 8 | 2018 | 15 | |
| 9 | 2018 | 7 | |
| 10 | 2018 | 2 | |
| 11 | 2018 | 1 | |
| 12 | 2018 | 1 |
About Katherine P. Hoversten
Katherine P. Hoversten is a scholar working on Genetics, Hematology, Oncology, Rheumatology and Immunology, having authored 12 papers that have together received 372 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Eosinophilic Disorders and Syndromes (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Mast cells and histamine (1 paper). The work is most often cited by research in Hematology (166 citations), Genetics (113 citations), Rehabilitation (24 citations), Oncology (81 citations) and Public Health, Environmental and Occupational Health (46 citations). Katherine P. Hoversten has collaborated with scholars based in United States. Frequent co-authors include Naseema Gangat, Ayalew Tefferi, Mrinal Patnaik, Christy M. Finke, Terra L. Lasho, Rhett P. Ketterling, Narjust Duma, Curtis A. Hanson, Rangit Reddy Vallapureddy and Kathryn J. Ruddy. Their work appears in journals such as American Journal of Hematology, The Oncologist, Annals of Oncology, Mayo Clinic Proceedings and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.